Why certain posters may wish to delay the introduction of bio effectives inc. Reopren- from the Solagran info late in 2007.
"The fact that Solagran’s Bioeffectives® display such a high degree of
efficacy, while generating few if any side effects, would be anathema to the
industry." (current pharmaceutical industry)
The pharma industry does not like non chemical success stories which do not generate side effects which then require more drugs. They don;t want solutions they want sales. SLA provides a potential solution.
- Forums
- ASX - By Stock
- SLA
- ropren facts
ropren facts, page-20
-
- There are more pages in this discussion • 75 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online